{"id":"https://openalex.org/W2051154442","doi":"https://doi.org/10.1111/j.1528-1157.1996.tb06038.x","title":"Update on the Mechanism of Action of Antiepileptic Drugs","display_name":"Update on the Mechanism of Action of Antiepileptic Drugs","publication_year":1996,"publication_date":"1996-12-01","ids":{"openalex":"https://openalex.org/W2051154442","doi":"https://doi.org/10.1111/j.1528-1157.1996.tb06038.x","mag":"2051154442","pmid":"https://pubmed.ncbi.nlm.nih.gov/8941036"},"language":"en","primary_location":{"id":"doi:10.1111/j.1528-1157.1996.tb06038.x","doi":"https://doi.org/10.1111/j.1528-1157.1996.tb06038.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1528-1157.1996.tb06038.x","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109988387","display_name":"Brian S. Meldrum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Brian S. Meldrum","raw_affiliation_strings":["Department of Neurology, University of London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of London, England","institution_ids":["https://openalex.org/I124357947"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109988387"],"corresponding_institution_ids":["https://openalex.org/I124357947"],"apc_list":{"value":4360,"currency":"USD","value_usd":4360},"apc_paid":null,"fwci":3.4347,"has_fulltext":false,"cited_by_count":251,"citation_normalized_percentile":{"value":0.93939394,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"37","issue":"s6","first_page":"S4","last_page":"11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.011699999682605267,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.9440000057220459},{"id":"https://openalex.org/keywords/voltage-gated-ion-channels","display_name":"voltage-gated ion channels","score":0.8939999938011169},{"id":"https://openalex.org/keywords/sodium-channel-inactivation","display_name":"sodium channel inactivation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/gabaergic-inhibition","display_name":"GABAergic inhibition","score":0.7789999842643738},{"id":"https://openalex.org/keywords/gaba-transaminase-inhibition","display_name":"GABA transaminase inhibition","score":0.8349999785423279},{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9539999961853027},{"id":"https://openalex.org/keywords/tiagabine","display_name":"tiagabine","score":0.9670000076293945},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.996999979019165},{"id":"https://openalex.org/keywords/remacemide","display_name":"remacemide","score":0.9369999766349792},{"id":"https://openalex.org/keywords/felbamate","display_name":"felbamate","score":0.9789999723434448},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nmda-receptor-blockade","display_name":"NMDA receptor blockade","score":0.9449999928474426},{"id":"https://openalex.org/keywords/l-type-calcium-channel-blockade","display_name":"L-type calcium channel blockade","score":0.875},{"id":"https://openalex.org/keywords/ampa-receptors","display_name":"AMPA receptors","score":0.6859999895095825},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C2781011581","wikidata":"https://www.wikidata.org/wiki/Q421301","display_name":"Felbamate","level":4,"score":0.8224233984947205},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.7234913110733032},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7093023657798767},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6463095545768738},{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.6405735015869141},{"id":"https://openalex.org/C50952357","wikidata":"https://www.wikidata.org/wiki/Q424960","display_name":"Sodium channel","level":3,"score":0.6217557787895203},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.5840811729431152},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.5623475909233093},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.5570138692855835},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.5047882795333862},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4886665642261505},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.48599085211753845},{"id":"https://openalex.org/C112592302","wikidata":"https://www.wikidata.org/wiki/Q1207387","display_name":"Excitatory postsynaptic potential","level":3,"score":0.4767395257949829},{"id":"https://openalex.org/C2777421860","wikidata":"https://www.wikidata.org/wiki/Q4637204","display_name":"GABA transaminase","level":4,"score":0.4564611315727234},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.308698832988739},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3075580596923828},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.2555582523345947},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.19675368070602417},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18746799230575562},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1581439971923828},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15726560354232788},{"id":"https://openalex.org/C9497952","wikidata":"https://www.wikidata.org/wiki/Q419650","display_name":"Glutamate decarboxylase","level":3,"score":0.05990952253341675},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078308","descriptor_name":"Tiagabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078328","descriptor_name":"Felbamate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000612","descriptor_name":"4-Aminobutyrate Transaminase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007473","descriptor_name":"Ion Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008564","descriptor_name":"Membrane Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009557","descriptor_name":"Nipecotic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009557","descriptor_name":"Nipecotic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011409","descriptor_name":"Propylene Glycols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011409","descriptor_name":"Propylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018091","descriptor_name":"Receptors, AMPA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1528-1157.1996.tb06038.x","doi":"https://doi.org/10.1111/j.1528-1157.1996.tb06038.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1528-1157.1996.tb06038.x","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},{"id":"pmid:8941036","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8941036","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W160527616","https://openalex.org/W1483005194","https://openalex.org/W1816535894","https://openalex.org/W1836738800","https://openalex.org/W1957753057","https://openalex.org/W1963530961","https://openalex.org/W1966229711","https://openalex.org/W1969032718","https://openalex.org/W1971931358","https://openalex.org/W1972382865","https://openalex.org/W1975239250","https://openalex.org/W1981229408","https://openalex.org/W1991325525","https://openalex.org/W1994296413","https://openalex.org/W2002331174","https://openalex.org/W2004010919","https://openalex.org/W2010241032","https://openalex.org/W2014872544","https://openalex.org/W2014971354","https://openalex.org/W2018671604","https://openalex.org/W2021334241","https://openalex.org/W2022145302","https://openalex.org/W2024435902","https://openalex.org/W2036646514","https://openalex.org/W2038250290","https://openalex.org/W2040408852","https://openalex.org/W2040475489","https://openalex.org/W2042870108","https://openalex.org/W2051875864","https://openalex.org/W2054447736","https://openalex.org/W2063792905","https://openalex.org/W2065798366","https://openalex.org/W2068799335","https://openalex.org/W2070993564","https://openalex.org/W2074144357","https://openalex.org/W2075723143","https://openalex.org/W2076980678","https://openalex.org/W2079065235","https://openalex.org/W2081758626","https://openalex.org/W2083044207","https://openalex.org/W2091064465","https://openalex.org/W2095088563","https://openalex.org/W2103289578","https://openalex.org/W2106915249","https://openalex.org/W2108809108","https://openalex.org/W2109746889","https://openalex.org/W2116471965","https://openalex.org/W2148082810","https://openalex.org/W2149922711","https://openalex.org/W2162356905","https://openalex.org/W2165630646","https://openalex.org/W2165900976","https://openalex.org/W2170787296","https://openalex.org/W2171682691","https://openalex.org/W2249220406","https://openalex.org/W2268187232","https://openalex.org/W2292111191","https://openalex.org/W2407440461","https://openalex.org/W4319308579"],"related_works":["https://openalex.org/W100576144","https://openalex.org/W2108809108","https://openalex.org/W2139593954","https://openalex.org/W2158562453","https://openalex.org/W2126863817","https://openalex.org/W2411274320","https://openalex.org/W2249279090","https://openalex.org/W2530904357","https://openalex.org/W200645246","https://openalex.org/W2050288732"],"abstract_inverted_index":{"Novel":[0],"antiepileptic":[1],"drugs":[2],"(AEDs)":[3],"are":[4,30,147],"thought":[5],"to":[6,63],"act":[7],"on":[8,12,16],"voltage-sensitive":[9],"ion":[10],"channels,":[11,91,110],"inhibitory":[13],"neurotransmission":[14],"or":[15],"excitatory":[17],"neurotransmission.":[18],"Two":[19],"successful":[20],"examples":[21],"of":[22,36,49,56,65,71,106,125,130,137,143,157,160],"rational":[23],"AED":[24],"design":[25],"that":[26],"potentiate":[27],"GABA-mediated":[28,86,131],"inhibition":[29,35,132],"vigabatrin":[31],"(VGB)":[32],"by":[33,41,75,153],"irreversible":[34],"GABA-transaminase,":[37],"and":[38,68,92,113,133],"tiagabine":[39],"(TGB)":[40],"blocking":[42],"GABA":[43,111],"uptake.":[44],"Lamotrigine":[45],"(LTG)":[46],"prolongs":[47,95],"inactivation":[48,70,136],"voltage-dependent":[50],"sodium":[51,72,96,109,138],"channels.":[52,139],"The":[53,140],"anticonvulsant":[54],"action":[55],"remacemide":[57],"(RCM)":[58],"is":[59],"probably":[60,127],"largely":[61],"due":[62],"blockade":[64],"NMDA":[66,83],"receptors":[67],"prolonged":[69],"channels":[73],"induced":[74],"its":[76],"desglycinated":[77],"metabolite.":[78],"Felbamate":[79],"(FBM)":[80],"apparently":[81,119],"blocks":[82,88],"receptors,":[84,112],"potentiates":[85],"responses,":[87],"L-type":[89],"calcium":[90],"possibly":[93,134],"also":[94,135],"channel":[97],"inactivation.":[98],"Similarly,":[99],"topiramate":[100],"(TPM)":[101],"has":[102,120],"multiple":[103],"probable":[104],"sites":[105],"action,":[107,126],"including":[108],"glutamate":[114],"(AMPA)":[115],"receptors.":[116],"Gabapentin":[117],"(GBP)":[118],"a":[121],"completely":[122],"novel":[123,145],"type":[124],"involving":[128],"potentiation":[129],"therapeutic":[141],"advantages":[142],"the":[144],"AEDs":[146],"as":[148],"yet":[149],"only":[150],"partially":[151],"explained":[152],"our":[154],"present":[155],"understanding":[156],"their":[158],"mechanisms":[159],"action.":[161]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}